Zobrazeno 1 - 10
of 634
pro vyhledávání: '"V Craig Jordan"'
Publikováno v:
PLoS ONE, Vol 8, Iss 6, p e62361 (2014)
Prolactin-induced Protein (PIP), an aspartyl protease unessential for normal mammalian cell function, is required for the proliferation and invasion of some breast cancer (BCa) cell types. Because PIP expression is particularly high in the Luminal A
Externí odkaz:
https://doaj.org/article/3679af9b2e2a495099c101cdaba2de3b
Autor:
Zhang-Zhi Hu, Benjamin L Kagan, Eric A Ariazi, Dean S Rosenthal, Lihua Zhang, Jordan V Li, Hongzhan Huang, Cathy Wu, V Craig Jordan, Anna T Riegel, Anton Wellstein
Publikováno v:
PLoS ONE, Vol 6, Iss 6, p e20410 (2011)
Estrogen is a known growth promoter for estrogen receptor (ER)-positive breast cancer cells. Paradoxically, in breast cancer cells that have been chronically deprived of estrogen stimulation, re-introduction of the hormone can induce apoptosis.Here,
Externí odkaz:
https://doaj.org/article/b8fa463ae9a04f6a9a24e7fc8b072c4a
Autor:
Herjan J. T. Coelingh Bennink, Iman J. Schultz, Marcus Schmidt, V. Craig Jordan, Paula Briggs, Jan F. M. Egberts, Kristina Gemzell-Danielsson, Ludwig Kiesel, Kirsten Kluivers, Jan Krijgh, Tommaso Simoncini, Frank Z. Stanczyk, Robert D. Langer
Publikováno v:
Breast Cancer Research, Vol 25, Iss 1, Pp 1-16 (2023)
Abstract Many factors, including reproductive hormones, have been linked to a woman’s risk of developing breast cancer (BC). We reviewed the literature regarding the relationship between ovulatory menstrual cycles (MCs) and BC risk. Physiological v
Externí odkaz:
https://doaj.org/article/29597ca8e60744538de2e4f76d9a93a7
Autor:
V Craig Jordan
This volume presents the evolution of the authors'ideas about estrogen action and its modulation by a new group of drugs called SERMs (Selective Estrogen Receptor Modulators). The pioneering SERMs — tamoxifen and raloxifene — are known to have sa
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
Antiestrogen therapy of breast cancer has been a “gold standard” of treatment of estrogen receptor (ER)-positive breast cancer for decades. Resistance to antiestrogen therapy may develop, however, a vulnerability in long-term estrogen deprived (L
Externí odkaz:
https://doaj.org/article/5548db30faab4a6b90012fcb9d745549
Autor:
Milene Volpato, Michele Cummings, Abeer M. Shaaban, Balkees Abderrahman, Mark A. Hull, Philipp Y. Maximov, Bradley M. Broom, Reiner Hoppe, Ping Fan, Hiltrud Brauch, V. Craig Jordan, Valerie Speirs
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 1, Iss 5, Pp 355-371 (2020)
Aim: Tamoxifen (TAM) resistance remains a clinical issue in breast cancer. The authors previously reported that 15-hydroxyprostaglandin dehydrogenase (HPGD) was significantly downregulated in tamoxifen-resistant (TAMr) breast cancer cell lines. Here,
Externí odkaz:
https://doaj.org/article/bf4233ab80be4b31b45c44845654b879
Autor:
Joan S. Lewis-Wambi, Helen R. Kim, Chris Wambi, Roshani Patel, Jennifer R. Pyle, Andres J. Klein-Szanto, V. Craig Jordan
Publikováno v:
Breast Cancer Research, Vol 20, Iss 1, Pp 1-3 (2018)
After the publication of this work [1] an error was noticed in Fig. 3a and Fig. 5a.
Externí odkaz:
https://doaj.org/article/869528e334ce40f1b3222590f45fabd4
Autor:
Robert Clarke, V. Craig Jordan, Poulomi Bhattacharya, Catherine M. Sevigny, Surojeet Sengupta
Details of Primary antibody sources
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d8dbeb11499a83a5fdef0575ebc4c5e
https://doi.org/10.1158/1541-7786.22515726.v1
https://doi.org/10.1158/1541-7786.22515726.v1
E2 suppressed the expression of PPARγ target gene ACOX3 in three breast cancer cell lines. MCF-7 cells were transferred from phenol red containing medium to E2-free medium for 3 days. Next, (A) MCF-7, (B) MCF-7:5C, and (C) MCF-7:2A cells were seeded
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9524b311dc06c10efdcf3c93fd811105
https://doi.org/10.1158/1535-7163.22504924
https://doi.org/10.1158/1535-7163.22504924